Menu
GWAS Study

Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis.

Hinks A, Cobb J, Marion MC et al.

23603761 PubMed ID
GWAS Study Type
15872 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HA
Hinks A
CJ
Cobb J
MM
Marion MC
PS
Prahalad S
SM
Sudman M
BJ
Bowes J
MP
Martin P
CM
Comeau ME
SS
Sajuthi S
AR
Andrews R
BM
Brown M
CW
Chen WM
CP
Concannon P
DP
Deloukas P
ES
Edkins S
ES
Eyre S
GP
Gaffney PM
GS
Guthery SL
GJ
Guthridge JM
HS
Hunt SE
JJ
James JA
KM
Keddache M
MK
Moser KL
NP
Nigrovic PA
OS
Onengut-Gumuscu S
OM
Onslow ML
RC
Rosé CD
RS
Rich SS
SK
Steel KJ
WE
Wakeland EK
WC
Wallace CA
WL
Wedderburn LR
WP
Woo P
BJ
Bohnsack JF
HJ
Haas JP
GD
Glass DN
LC
Langefeld CD
TW
Thomson W
TS
Thompson SD
Chapter II

Abstract

Summary of the research findings

We used the Immunochip array to analyze 2,816 individuals with juvenile idiopathic arthritis (JIA), comprising the most common subtypes (oligoarticular and rheumatoid factor-negative polyarticular JIA), and 13,056 controls. We confirmed association of 3 known JIA risk loci (the human leukocyte antigen (HLA) region, PTPN22 and PTPN2) and identified 14 loci reaching genome-wide significance (P < 5 × 10(-8)) for the first time. Eleven additional new regions showed suggestive evidence of association with JIA (P < 1 × 10(-6)). Dense mapping of loci along with bioinformatics analysis refined the associations to one gene in each of eight regions, highlighting crucial pathways, including the interleukin (IL)-2 pathway, in JIA disease pathogenesis. The entire Immunochip content, the HLA region and the top 27 loci (P < 1 × 10(-6)) explain an estimated 18, 13 and 6% of the risk of JIA, respectively. In summary, this is the largest collection of JIA cases investigated so far and provides new insight into the genetic basis of this childhood autoimmune disease.

2,816 European ancestry cases, 13,056 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

15872
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Germany, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.